VARIABLE Male (n=129) Female (n=37) P
LDL-C 108 ± 36 110 ± 32 0.84
TG 144 (83, 226) 103 (85, 131) 0.016
RLP-C 9.3 (6.5, 16.6) 7.8 (6.4, 11.0) 0.062
NEFA 0.3 (0.2, 0.4) 0.4 (0.3, 0.5) 0.011
Apo-B 87 ± 23 79 ± 18 0.037
LP(a) 17 (7, 53) 23 (13, 33) 0.36
HDL-C 35 (28, 46) 48 (33, 61) 0.004
HDL-TG 17 (11, 26) 17 (14, 21) 0.99
ApoA-I 122 ± 26 138 ± 32 0.003
ApoA-II 35 ± 9 34 ± 11 0.36
ApoE 4.0 (3.3, 5.4) 4.4 (3.6, 5.2) 0.41
Preβ-1 36 (29, 46) 36 (25, 47) 0.40
Preβ-2 1.5 (1.1, 2.9) 1.7 (1.1, 2.8) 0.58
α-1 9 (5, 14) 17 (9, 29) < 0.001
α-2 26 (22, 33) 35 (26, 40) 0.002
α-3 23 (18, 28) 20 (15, 28) 0.28
α-4 7 (5, 10) 7 (6, 10) 0.59
Preα-1 2 (1, 4) 4 (2, 11) 0.002
Preα-2 3 (2, 5) 4 (3, 8) 0.034
Preα-3 3  (2, 4) 3 (2, 4) 0.41
Preα-4 1.2 (0.7, 1.6) 1.1 (0.6, 1.8) 0.95
CETP (μg/mL) 2 (2, 3) 2 (2, 3) 0.66
LCAT (μg/mL) 7 (6, 8) 7 (6, 8) 0.42
CETP Activity (μg/mL/hour) 0.3 (-1.3, 1.8) 0.8 (-0.7, 2.0) 0.36
LCAT Activity (μg/mL/hour) 17 (10, 27) 13 (8, 30) 0.39
Values are mg/dL or as indicated.
Normally distributed parameters are expressed as average ± SD.
Not normally distributed parameters are expressed as median (min, max).<
Table 1b: Lipoprotein-associated parameters in subjects grouped by gender.
Goto home»